Bristol hires ImClone manufacturing exec
ImClone Senior VP-Manufacturing Operations & Product Development Joseph Tarnowski will join Bristol-Myers Squibb as senior VP-biologics, manufacturing and process development. ImClone VP-Manufacturing Richard Crowley will take over for Tarnowski as senior VP- biopharmaceutical operations, overseeing the company's biologics manufacturing operations. Crowley joined ImClone in 2000 as assistant VP-manufacturing and was promoted to VP-manufacturing in 2002. Prior to joining ImClone, Crowley held positions at BASF, Genencor International, Eastman Kodak and Monsanto...
You may also be interested in...
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.